nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP3A4—bone cancer	0.776	1	CbGaD
Bupivacaine—Lidocaine—EGFR—bone cancer	0.00228	0.305	CrCbGaD
Bupivacaine—Levobupivacaine—CYP3A4—bone cancer	0.00178	0.238	CrCbGaD
Bupivacaine—Ranolazine—CYP3A4—bone cancer	0.00145	0.194	CrCbGaD
Bupivacaine—Ropivacaine—CYP3A4—bone cancer	0.00115	0.153	CrCbGaD
Bupivacaine—Lidocaine—CYP3A4—bone cancer	0.000835	0.111	CrCbGaD
Bupivacaine—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.000592	0.0879	CbGpPWpGaD
Bupivacaine—Flushing—Cisplatin—bone cancer	0.00057	0.00271	CcSEcCtD
Bupivacaine—Pulmonary oedema—Epirubicin—bone cancer	0.000559	0.00266	CcSEcCtD
Bupivacaine—Arrhythmia—Cisplatin—bone cancer	0.000549	0.00261	CcSEcCtD
Bupivacaine—Neuropathy—Doxorubicin—bone cancer	0.000546	0.0026	CcSEcCtD
Bupivacaine—Erythema—Cisplatin—bone cancer	0.000535	0.00255	CcSEcCtD
Bupivacaine—Malnutrition—Cisplatin—bone cancer	0.000535	0.00255	CcSEcCtD
Bupivacaine—Flatulence—Cisplatin—bone cancer	0.000527	0.00251	CcSEcCtD
Bupivacaine—Pulmonary oedema—Doxorubicin—bone cancer	0.000517	0.00246	CcSEcCtD
Bupivacaine—Muscle spasms—Cisplatin—bone cancer	0.000514	0.00245	CcSEcCtD
Bupivacaine—Vascular purpura—Epirubicin—bone cancer	0.00051	0.00243	CcSEcCtD
Bupivacaine—Vision blurred—Cisplatin—bone cancer	0.000504	0.0024	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Methotrexate—bone cancer	0.000504	0.0024	CcSEcCtD
Bupivacaine—Tremor—Cisplatin—bone cancer	0.000501	0.00239	CcSEcCtD
Bupivacaine—Lethargy—Methotrexate—bone cancer	0.000497	0.00237	CcSEcCtD
Bupivacaine—Anaemia—Cisplatin—bone cancer	0.000494	0.00235	CcSEcCtD
Bupivacaine—Osteoarthritis—Methotrexate—bone cancer	0.000487	0.00232	CcSEcCtD
Bupivacaine—Purpura—Epirubicin—bone cancer	0.000473	0.00225	CcSEcCtD
Bupivacaine—Vascular purpura—Doxorubicin—bone cancer	0.000472	0.00225	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Epirubicin—bone cancer	0.000471	0.00224	CcSEcCtD
Bupivacaine—Lethargy—Epirubicin—bone cancer	0.000465	0.00222	CcSEcCtD
Bupivacaine—Convulsion—Cisplatin—bone cancer	0.000463	0.00221	CcSEcCtD
Bupivacaine—Osteoarthritis—Epirubicin—bone cancer	0.000456	0.00217	CcSEcCtD
Bupivacaine—Diplopia—Epirubicin—bone cancer	0.000456	0.00217	CcSEcCtD
Bupivacaine—Anxiety—Cisplatin—bone cancer	0.000454	0.00216	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000452	0.00215	CcSEcCtD
Bupivacaine—Purpura—Doxorubicin—bone cancer	0.000438	0.00208	CcSEcCtD
Bupivacaine—Anaphylactic shock—Cisplatin—bone cancer	0.000436	0.00208	CcSEcCtD
Bupivacaine—Oedema—Cisplatin—bone cancer	0.000436	0.00208	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000436	0.00208	CcSEcCtD
Bupivacaine—Cardiac arrest—Epirubicin—bone cancer	0.000434	0.00206	CcSEcCtD
Bupivacaine—Infection—Cisplatin—bone cancer	0.000434	0.00206	CcSEcCtD
Bupivacaine—Lethargy—Doxorubicin—bone cancer	0.000431	0.00205	CcSEcCtD
Bupivacaine—Nervous system disorder—Cisplatin—bone cancer	0.000428	0.00204	CcSEcCtD
Bupivacaine—Blood creatinine increased—Epirubicin—bone cancer	0.000427	0.00203	CcSEcCtD
Bupivacaine—Tachycardia—Cisplatin—bone cancer	0.000426	0.00203	CcSEcCtD
Bupivacaine—Skin disorder—Cisplatin—bone cancer	0.000424	0.00202	CcSEcCtD
Bupivacaine—Diplopia—Doxorubicin—bone cancer	0.000422	0.00201	CcSEcCtD
Bupivacaine—Osteoarthritis—Doxorubicin—bone cancer	0.000422	0.00201	CcSEcCtD
Bupivacaine—Hyperhidrosis—Cisplatin—bone cancer	0.000422	0.00201	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Epirubicin—bone cancer	0.000417	0.00198	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000411	0.00195	CcSEcCtD
Bupivacaine—Hypotension—Cisplatin—bone cancer	0.000408	0.00194	CcSEcCtD
Bupivacaine—Muscular weakness—Epirubicin—bone cancer	0.000402	0.00191	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000402	0.00191	CcSEcCtD
Bupivacaine—Cardiac arrest—Doxorubicin—bone cancer	0.000401	0.00191	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000398	0.00189	CcSEcCtD
Bupivacaine—Abdominal distension—Epirubicin—bone cancer	0.000397	0.00189	CcSEcCtD
Bupivacaine—Blood creatinine increased—Doxorubicin—bone cancer	0.000395	0.00188	CcSEcCtD
Bupivacaine—Dysphagia—Epirubicin—bone cancer	0.000394	0.00188	CcSEcCtD
Bupivacaine—Paraesthesia—Cisplatin—bone cancer	0.000392	0.00187	CcSEcCtD
Bupivacaine—Dyspnoea—Cisplatin—bone cancer	0.000389	0.00185	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Doxorubicin—bone cancer	0.000385	0.00183	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00038	0.00181	CcSEcCtD
Bupivacaine—Decreased appetite—Cisplatin—bone cancer	0.000379	0.00181	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000377	0.00179	CcSEcCtD
Bupivacaine—Infestation NOS—Methotrexate—bone cancer	0.000376	0.00179	CcSEcCtD
Bupivacaine—Infestation—Methotrexate—bone cancer	0.000376	0.00179	CcSEcCtD
Bupivacaine—Drowsiness—Methotrexate—bone cancer	0.000376	0.00179	CcSEcCtD
Bupivacaine—Pain—Cisplatin—bone cancer	0.000373	0.00178	CcSEcCtD
Bupivacaine—Muscular weakness—Doxorubicin—bone cancer	0.000372	0.00177	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000372	0.00177	CcSEcCtD
Bupivacaine—Abdominal distension—Doxorubicin—bone cancer	0.000367	0.00175	CcSEcCtD
Bupivacaine—Dysphagia—Doxorubicin—bone cancer	0.000365	0.00174	CcSEcCtD
Bupivacaine—Sweating—Methotrexate—bone cancer	0.00036	0.00171	CcSEcCtD
Bupivacaine—Feeling abnormal—Cisplatin—bone cancer	0.00036	0.00171	CcSEcCtD
Bupivacaine—Haematuria—Methotrexate—bone cancer	0.000358	0.0017	CcSEcCtD
Bupivacaine—Infestation NOS—Epirubicin—bone cancer	0.000351	0.00167	CcSEcCtD
Bupivacaine—Drowsiness—Epirubicin—bone cancer	0.000351	0.00167	CcSEcCtD
Bupivacaine—Infestation—Epirubicin—bone cancer	0.000351	0.00167	CcSEcCtD
Bupivacaine—Body temperature increased—Cisplatin—bone cancer	0.000345	0.00164	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Epirubicin—bone cancer	0.000345	0.00164	CcSEcCtD
Bupivacaine—Urinary tract infection—Epirubicin—bone cancer	0.000342	0.00163	CcSEcCtD
Bupivacaine—Sweating—Epirubicin—bone cancer	0.000337	0.0016	CcSEcCtD
Bupivacaine—Haematuria—Epirubicin—bone cancer	0.000335	0.0016	CcSEcCtD
Bupivacaine—Drowsiness—Doxorubicin—bone cancer	0.000325	0.00155	CcSEcCtD
Bupivacaine—Infestation NOS—Doxorubicin—bone cancer	0.000325	0.00155	CcSEcCtD
Bupivacaine—Infestation—Doxorubicin—bone cancer	0.000325	0.00155	CcSEcCtD
Bupivacaine—Hypersensitivity—Cisplatin—bone cancer	0.000322	0.00153	CcSEcCtD
Bupivacaine—Bradycardia—Epirubicin—bone cancer	0.000321	0.00153	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Doxorubicin—bone cancer	0.000319	0.00152	CcSEcCtD
Bupivacaine—Urinary tract infection—Doxorubicin—bone cancer	0.000316	0.0015	CcSEcCtD
Bupivacaine—Tinnitus—Methotrexate—bone cancer	0.000314	0.0015	CcSEcCtD
Bupivacaine—Hypoaesthesia—Epirubicin—bone cancer	0.000314	0.00149	CcSEcCtD
Bupivacaine—Asthenia—Cisplatin—bone cancer	0.000313	0.00149	CcSEcCtD
Bupivacaine—Cardiac disorder—Methotrexate—bone cancer	0.000313	0.00149	CcSEcCtD
Bupivacaine—Sweating—Doxorubicin—bone cancer	0.000312	0.00148	CcSEcCtD
Bupivacaine—Oedema peripheral—Epirubicin—bone cancer	0.000311	0.00148	CcSEcCtD
Bupivacaine—Haematuria—Doxorubicin—bone cancer	0.00031	0.00148	CcSEcCtD
Bupivacaine—Chills—Methotrexate—bone cancer	0.000303	0.00144	CcSEcCtD
Bupivacaine—Diarrhoea—Cisplatin—bone cancer	0.000299	0.00142	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—bone cancer	0.000297	0.00141	CcSEcCtD
Bupivacaine—Mental disorder—Methotrexate—bone cancer	0.000295	0.00141	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—bone cancer	0.000294	0.0014	CcSEcCtD
Bupivacaine—Malnutrition—Methotrexate—bone cancer	0.000293	0.0014	CcSEcCtD
Bupivacaine—Erythema—Methotrexate—bone cancer	0.000293	0.0014	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—bone cancer	0.000293	0.00139	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—bone cancer	0.000293	0.00139	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—bone cancer	0.00029	0.00138	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—bone cancer	0.000288	0.00137	CcSEcCtD
Bupivacaine—Back pain—Methotrexate—bone cancer	0.000284	0.00135	CcSEcCtD
Bupivacaine—Chills—Epirubicin—bone cancer	0.000283	0.00135	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—bone cancer	0.000282	0.00134	CcSEcCtD
Bupivacaine—Vomiting—Cisplatin—bone cancer	0.000278	0.00132	CcSEcCtD
Bupivacaine—Vision blurred—Methotrexate—bone cancer	0.000277	0.00132	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—bone cancer	0.000276	0.00132	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—bone cancer	0.000275	0.00131	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—bone cancer	0.000275	0.00131	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—bone cancer	0.000272	0.0013	CcSEcCtD
Bupivacaine—Anaemia—Methotrexate—bone cancer	0.000271	0.00129	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—bone cancer	0.000271	0.00129	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—bone cancer	0.000271	0.00129	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—bone cancer	0.000271	0.00129	CcSEcCtD
Bupivacaine—Tension—Epirubicin—bone cancer	0.00027	0.00128	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—bone cancer	0.000267	0.00127	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—bone cancer	0.000266	0.00126	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—bone cancer	0.000264	0.00126	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—bone cancer	0.000262	0.00125	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—bone cancer	0.000261	0.00124	CcSEcCtD
Bupivacaine—Nausea—Cisplatin—bone cancer	0.000259	0.00123	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—bone cancer	0.000259	0.00123	CcSEcCtD
Bupivacaine—Cough—Methotrexate—bone cancer	0.000256	0.00122	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—bone cancer	0.000256	0.00122	CcSEcCtD
Bupivacaine—Convulsion—Methotrexate—bone cancer	0.000254	0.00121	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—bone cancer	0.000254	0.00121	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—bone cancer	0.000254	0.00121	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—bone cancer	0.000254	0.00121	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—bone cancer	0.000252	0.0012	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—bone cancer	0.00025	0.00119	CcSEcCtD
Bupivacaine—Arthralgia—Methotrexate—bone cancer	0.00025	0.00119	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—bone cancer	0.000249	0.00119	CcSEcCtD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000249	0.037	CbGpPWpGaD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000248	0.00118	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—bone cancer	0.000247	0.00117	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—bone cancer	0.000246	0.00117	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—bone cancer	0.000246	0.00117	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—bone cancer	0.000244	0.00116	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—bone cancer	0.000243	0.00116	CcSEcCtD
Bupivacaine—Confusional state—Methotrexate—bone cancer	0.000242	0.00115	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—bone cancer	0.000241	0.00115	CcSEcCtD
Bupivacaine—Cough—Epirubicin—bone cancer	0.00024	0.00114	CcSEcCtD
Bupivacaine—Anaphylactic shock—Methotrexate—bone cancer	0.00024	0.00114	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—bone cancer	0.000239	0.00114	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—bone cancer	0.000238	0.00113	CcSEcCtD
Bupivacaine—Infection—Methotrexate—bone cancer	0.000238	0.00113	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—bone cancer	0.000237	0.00113	CcSEcCtD
Bupivacaine—Nervous system disorder—Methotrexate—bone cancer	0.000235	0.00112	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—bone cancer	0.000235	0.00112	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—bone cancer	0.000234	0.00111	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—bone cancer	0.000234	0.00111	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—bone cancer	0.000233	0.00111	CcSEcCtD
Bupivacaine—Skin disorder—Methotrexate—bone cancer	0.000233	0.00111	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000232	0.00111	CcSEcCtD
Bupivacaine—Hyperhidrosis—Methotrexate—bone cancer	0.000232	0.0011	CcSEcCtD
Bupivacaine—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00023	0.0342	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000229	0.0341	CbGpPWpGaD
Bupivacaine—Syncope—Doxorubicin—bone cancer	0.000228	0.00108	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—bone cancer	0.000226	0.00108	CcSEcCtD
Bupivacaine—Palpitations—Doxorubicin—bone cancer	0.000225	0.00107	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—bone cancer	0.000224	0.00107	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—bone cancer	0.000224	0.00107	CcSEcCtD
Bupivacaine—Hypotension—Methotrexate—bone cancer	0.000224	0.00107	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—bone cancer	0.000223	0.00106	CcSEcCtD
Bupivacaine—Infection—Epirubicin—bone cancer	0.000223	0.00106	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—bone cancer	0.000222	0.00106	CcSEcCtD
Bupivacaine—Shock—Epirubicin—bone cancer	0.000221	0.00105	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—bone cancer	0.00022	0.00105	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—bone cancer	0.00022	0.00105	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—bone cancer	0.000219	0.00104	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—bone cancer	0.000219	0.00104	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000218	0.00104	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—bone cancer	0.000218	0.00104	CcSEcCtD
Bupivacaine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000217	0.0323	CbGpPWpGaD
Bupivacaine—Hyperhidrosis—Epirubicin—bone cancer	0.000217	0.00103	CcSEcCtD
Bupivacaine—Insomnia—Methotrexate—bone cancer	0.000217	0.00103	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—bone cancer	0.000216	0.00103	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—bone cancer	0.000216	0.00103	CcSEcCtD
Bupivacaine—Paraesthesia—Methotrexate—bone cancer	0.000215	0.00102	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000215	0.00102	CcSEcCtD
Bupivacaine—Dyspnoea—Methotrexate—bone cancer	0.000214	0.00102	CcSEcCtD
Bupivacaine—Somnolence—Methotrexate—bone cancer	0.000213	0.00101	CcSEcCtD
Bupivacaine—Dyspepsia—Methotrexate—bone cancer	0.000211	0.001	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—bone cancer	0.000209	0.000997	CcSEcCtD
Bupivacaine—Confusional state—Doxorubicin—bone cancer	0.000209	0.000995	CcSEcCtD
Bupivacaine—Decreased appetite—Methotrexate—bone cancer	0.000208	0.000991	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—bone cancer	0.000207	0.000987	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—bone cancer	0.000207	0.000987	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000207	0.000984	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—bone cancer	0.000206	0.000981	CcSEcCtD
Bupivacaine—Pain—Methotrexate—bone cancer	0.000205	0.000975	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000204	0.000972	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—bone cancer	0.000204	0.000971	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—bone cancer	0.000203	0.000968	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—bone cancer	0.000203	0.000965	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—bone cancer	0.000202	0.000964	CcSEcCtD
Bupivacaine—Skin disorder—Doxorubicin—bone cancer	0.000201	0.000959	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—bone cancer	0.000201	0.000958	CcSEcCtD
Bupivacaine—Hyperhidrosis—Doxorubicin—bone cancer	0.000201	0.000954	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—bone cancer	0.0002	0.000951	CcSEcCtD
Bupivacaine—Somnolence—Epirubicin—bone cancer	0.000199	0.000949	CcSEcCtD
Bupivacaine—Feeling abnormal—Methotrexate—bone cancer	0.000197	0.00094	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—bone cancer	0.000197	0.000939	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Methotrexate—bone cancer	0.000196	0.000932	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—bone cancer	0.000195	0.000928	CcSEcCtD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000194	0.0289	CbGpPWpGaD
Bupivacaine—Hypotension—Doxorubicin—bone cancer	0.000194	0.000923	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000194	0.000921	CcSEcCtD
Bupivacaine—Pain—Epirubicin—bone cancer	0.000192	0.000912	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—bone cancer	0.000192	0.000912	CcSEcCtD
Bupivacaine—Urticaria—Methotrexate—bone cancer	0.00019	0.000906	CcSEcCtD
Bupivacaine—Abdominal pain—Methotrexate—bone cancer	0.000189	0.000901	CcSEcCtD
Bupivacaine—Body temperature increased—Methotrexate—bone cancer	0.000189	0.000901	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000189	0.000899	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—bone cancer	0.000188	0.000893	CcSEcCtD
Bupivacaine—Paraesthesia—Doxorubicin—bone cancer	0.000186	0.000887	CcSEcCtD
Bupivacaine—Dyspnoea—Doxorubicin—bone cancer	0.000185	0.00088	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—bone cancer	0.000185	0.000879	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—bone cancer	0.000184	0.000878	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—bone cancer	0.000183	0.000872	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—bone cancer	0.000183	0.000869	CcSEcCtD
Bupivacaine—Decreased appetite—Doxorubicin—bone cancer	0.00018	0.000858	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000179	0.000852	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—bone cancer	0.000178	0.000848	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—bone cancer	0.000177	0.000844	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—bone cancer	0.000177	0.000844	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—bone cancer	0.000177	0.000843	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—bone cancer	0.000177	0.000843	CcSEcCtD
Bupivacaine—Hypersensitivity—Methotrexate—bone cancer	0.000176	0.00084	CcSEcCtD
Bupivacaine—Asthenia—Methotrexate—bone cancer	0.000172	0.000818	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—bone cancer	0.000171	0.000814	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00017	0.000807	CcSEcCtD
Bupivacaine—Pruritus—Methotrexate—bone cancer	0.000169	0.000807	CcSEcCtD
Bupivacaine—Hypersensitivity—Epirubicin—bone cancer	0.000165	0.000786	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—bone cancer	0.000165	0.000784	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—bone cancer	0.000164	0.00078	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—bone cancer	0.000164	0.00078	CcSEcCtD
Bupivacaine—Diarrhoea—Methotrexate—bone cancer	0.000164	0.00078	CcSEcCtD
Bupivacaine—Asthenia—Epirubicin—bone cancer	0.000161	0.000766	CcSEcCtD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—bone cancer	0.000159	0.0236	CbGpPWpGaD
Bupivacaine—Pruritus—Epirubicin—bone cancer	0.000159	0.000755	CcSEcCtD
Bupivacaine—Dizziness—Methotrexate—bone cancer	0.000158	0.000754	CcSEcCtD
Bupivacaine—Diarrhoea—Epirubicin—bone cancer	0.000153	0.00073	CcSEcCtD
Bupivacaine—Hypersensitivity—Doxorubicin—bone cancer	0.000153	0.000727	CcSEcCtD
Bupivacaine—Vomiting—Methotrexate—bone cancer	0.000152	0.000725	CcSEcCtD
Bupivacaine—Headache—Methotrexate—bone cancer	0.00015	0.000714	CcSEcCtD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00015	0.0223	CbGpPWpGaD
Bupivacaine—Asthenia—Doxorubicin—bone cancer	0.000149	0.000708	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—bone cancer	0.000148	0.000706	CcSEcCtD
Bupivacaine—Pruritus—Doxorubicin—bone cancer	0.000147	0.000698	CcSEcCtD
Bupivacaine—Vomiting—Epirubicin—bone cancer	0.000143	0.000678	CcSEcCtD
Bupivacaine—Nausea—Methotrexate—bone cancer	0.000142	0.000677	CcSEcCtD
Bupivacaine—PTGER1—G alpha (q) signalling events—GRM1—bone cancer	0.000142	0.0211	CbGpPWpGaD
Bupivacaine—Diarrhoea—Doxorubicin—bone cancer	0.000142	0.000675	CcSEcCtD
Bupivacaine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000141	0.021	CbGpPWpGaD
Bupivacaine—Headache—Epirubicin—bone cancer	0.00014	0.000668	CcSEcCtD
Bupivacaine—Dizziness—Doxorubicin—bone cancer	0.000137	0.000653	CcSEcCtD
Bupivacaine—Nausea—Epirubicin—bone cancer	0.000133	0.000634	CcSEcCtD
Bupivacaine—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000132	0.0197	CbGpPWpGaD
Bupivacaine—Vomiting—Doxorubicin—bone cancer	0.000132	0.000628	CcSEcCtD
Bupivacaine—Headache—Doxorubicin—bone cancer	0.00013	0.000618	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM1—bone cancer	0.000127	0.0189	CbGpPWpGaD
Bupivacaine—Nausea—Doxorubicin—bone cancer	0.000123	0.000586	CcSEcCtD
Bupivacaine—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.00012	0.0179	CbGpPWpGaD
Bupivacaine—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000116	0.0172	CbGpPWpGaD
Bupivacaine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000112	0.0166	CbGpPWpGaD
Bupivacaine—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000111	0.0164	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000107	0.0159	CbGpPWpGaD
Bupivacaine—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000106	0.0158	CbGpPWpGaD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000105	0.0156	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000102	0.0152	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	9.87e-05	0.0147	CbGpPWpGaD
Bupivacaine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	9.77e-05	0.0145	CbGpPWpGaD
Bupivacaine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	9.38e-05	0.0139	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—GNA11—bone cancer	9.17e-05	0.0136	CbGpPWpGaD
Bupivacaine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	9.02e-05	0.0134	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	8.36e-05	0.0124	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—GRM4—bone cancer	8.28e-05	0.0123	CbGpPWpGaD
Bupivacaine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	8.26e-05	0.0123	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	8.2e-05	0.0122	CbGpPWpGaD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	8.1e-05	0.012	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—GRM1—bone cancer	7.17e-05	0.0107	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	6.45e-05	0.00958	CbGpPWpGaD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	6.13e-05	0.00911	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	5.29e-05	0.00785	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—SMO—bone cancer	5.06e-05	0.00751	CbGpPWpGaD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5e-05	0.00742	CbGpPWpGaD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.93e-05	0.00732	CbGpPWpGaD
Bupivacaine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	4.82e-05	0.00715	CbGpPWpGaD
Bupivacaine—SCN4A—L1CAM interactions—EGFR—bone cancer	4.69e-05	0.00697	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—GRM4—bone cancer	4.68e-05	0.00695	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—RGS1—bone cancer	4.68e-05	0.00695	CbGpPWpGaD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	4.6e-05	0.00683	CbGpPWpGaD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	4.54e-05	0.00674	CbGpPWpGaD
Bupivacaine—SCN10A—L1CAM interactions—EGFR—bone cancer	4.53e-05	0.00672	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GRM4—bone cancer	4.25e-05	0.00631	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RGS1—bone cancer	4.25e-05	0.00631	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—GRM1—bone cancer	4.05e-05	0.00602	CbGpPWpGaD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.05e-05	0.00602	CbGpPWpGaD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.89e-05	0.00578	CbGpPWpGaD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.84e-05	0.00571	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.73e-05	0.00553	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GRM1—bone cancer	3.68e-05	0.00547	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MET—bone cancer	3.5e-05	0.0052	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MET—bone cancer	3.38e-05	0.00502	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.16e-05	0.00469	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MMP2—bone cancer	2.92e-05	0.00434	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MMP2—bone cancer	2.82e-05	0.00418	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—GNA11—bone cancer	2.61e-05	0.00388	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.6e-05	0.00386	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—SMO—bone cancer	2.59e-05	0.00385	CbGpPWpGaD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	2.56e-05	0.0038	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RGS1—bone cancer	2.51e-05	0.00373	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GRM4—bone cancer	2.51e-05	0.00373	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MET—bone cancer	2.5e-05	0.00371	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CDK4—bone cancer	2.5e-05	0.00371	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	2.45e-05	0.00364	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MET—bone cancer	2.41e-05	0.00358	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CDK4—bone cancer	2.41e-05	0.00358	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GNA11—bone cancer	2.37e-05	0.00352	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL3—bone cancer	2.37e-05	0.00352	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.33e-05	0.00347	CbGpPWpGaD
Bupivacaine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	2.21e-05	0.00329	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MMP9—bone cancer	2.2e-05	0.00326	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GRM1—bone cancer	2.18e-05	0.00323	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP3A4—bone cancer	2.15e-05	0.0032	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL3—bone cancer	2.15e-05	0.0032	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	2.13e-05	0.00317	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	2.12e-05	0.00315	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MMP9—bone cancer	2.12e-05	0.00314	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP2—bone cancer	2.08e-05	0.0031	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP2—bone cancer	2.01e-05	0.00299	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	2e-05	0.00296	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	1.98e-05	0.00294	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	1.95e-05	0.0029	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.92e-05	0.00286	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—GSTP1—bone cancer	1.84e-05	0.00273	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	1.81e-05	0.0027	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—bone cancer	1.77e-05	0.00264	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—EGFR—bone cancer	1.71e-05	0.00254	CbGpPWpGaD
Bupivacaine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.71e-05	0.00254	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTP1—bone cancer	1.69e-05	0.00251	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.68e-05	0.00249	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	1.67e-05	0.00248	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.65e-05	0.00246	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP9—bone cancer	1.57e-05	0.00233	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMO—bone cancer	1.53e-05	0.00228	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.51e-05	0.00225	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.51e-05	0.00225	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP9—bone cancer	1.51e-05	0.00224	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.43e-05	0.00213	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.41e-05	0.0021	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GNA11—bone cancer	1.4e-05	0.00208	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ATF1—bone cancer	1.3e-05	0.00194	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NDUFA12—bone cancer	1.29e-05	0.00192	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL3—bone cancer	1.27e-05	0.00189	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—bone cancer	1.27e-05	0.00188	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—bone cancer	1.22e-05	0.00181	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NDUFA12—bone cancer	1.19e-05	0.00176	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTP1—bone cancer	1.11e-05	0.00164	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	1.09e-05	0.00162	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFBR2—bone cancer	1.09e-05	0.00161	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NT5C3A—bone cancer	1.07e-05	0.00159	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF1R—bone cancer	1.02e-05	0.00152	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NDUFA12—bone cancer	1e-05	0.00149	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NT5C3A—bone cancer	9.83e-06	0.00146	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NT5C3A—bone cancer	8.33e-06	0.00124	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NDUFA12—bone cancer	7.76e-06	0.00115	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KIT—bone cancer	7.42e-06	0.0011	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—BRAF—bone cancer	6.97e-06	0.00104	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—bone cancer	6.76e-06	0.001	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NT5C3A—bone cancer	6.43e-06	0.000955	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MDM2—bone cancer	5.84e-06	0.000868	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JUN—bone cancer	5.08e-06	0.000754	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—bone cancer	4.94e-06	0.000734	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ENO2—bone cancer	4.68e-06	0.000695	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—DHFR—bone cancer	4.34e-06	0.000645	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ENO2—bone cancer	4.31e-06	0.00064	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GNA11—bone cancer	4.06e-06	0.000603	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—DHFR—bone cancer	3.99e-06	0.000593	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—bone cancer	3.99e-06	0.000593	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GNA11—bone cancer	3.73e-06	0.000554	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP3A4—bone cancer	3.68e-06	0.000547	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.66e-06	0.000544	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ENO2—bone cancer	3.65e-06	0.000542	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP3A4—bone cancer	3.38e-06	0.000503	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—DHFR—bone cancer	3.38e-06	0.000503	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—bone cancer	3.35e-06	0.000498	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GNA11—bone cancer	3.16e-06	0.00047	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—bone cancer	3.15e-06	0.000467	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—bone cancer	2.89e-06	0.00043	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP3A4—bone cancer	2.87e-06	0.000426	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.85e-06	0.000424	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ENO2—bone cancer	2.81e-06	0.000418	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—DHFR—bone cancer	2.61e-06	0.000388	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—bone cancer	2.45e-06	0.000364	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GNA11—bone cancer	2.44e-06	0.000363	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—bone cancer	1.89e-06	0.000281	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—bone cancer	1.63e-06	0.000242	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—bone cancer	1.5e-06	0.000223	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—bone cancer	1.27e-06	0.000189	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—bone cancer	9.8e-07	0.000146	CbGpPWpGaD
